These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8270653)

  • 1. Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG.
    Hilfenhaus S; Cohen BJ; Bates C; Kajigaya S; Young NS; Zambon M; Mortimer PP
    J Virol Methods; 1993 Nov; 45(1):27-37. PubMed ID: 8270653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple haemadherence test for the detection of class-specific immunoglobulins to hepatitis A virus.
    Perry KR; Parry JV
    J Med Virol; 1993 Jan; 39(1):23-7. PubMed ID: 8380840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens.
    Cubel RC; Alferes AC; Cohen BJ; Nascimento JP
    J Clin Microbiol; 1994 Aug; 32(8):1997-9. PubMed ID: 7989556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
    Gray JJ; Cohen BJ; Desselberger U
    J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
    Salimans MM; van Bussel MJ; Brown CS; Spaan WJ
    J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.
    Cubel RC; Oliveira SA; Brown DW; Cohen BJ; Nascimento JP
    J Clin Microbiol; 1996 Jan; 34(1):205-7. PubMed ID: 8748306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W; Halim MA; Al-Nakib W
    Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
    J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
    AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of parvovirus B19 infection.
    Sevall JS; Ritenhous J; Peter JB
    J Clin Lab Anal; 1992; 6(4):171-5. PubMed ID: 1403335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM.
    Cohen BJ; Bates CM
    J Virol Methods; 1995 Sep; 55(1):11-25. PubMed ID: 8576300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS; Cohen BJ
    Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection].
    Nowalany-Kozielska E; Kozieł M; Domal-Kwiatkowska D; Dworniczak S; Wojnicz R; Wojciechowska C; Jachec W; Kawecki D; Smolik S; Weglarz L; Kozielski J
    Wiad Lek; 2012; 65(4):211-5. PubMed ID: 23654140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.